Tony Hunt
Chief Executive Officer at REPLIGEN CORPORATION
Net worth: 34 M $ as of 2024-03-30
Profile
Currently, Tony J. Hunt is President, Chief Executive Officer & Director at Repligen Corp. Mr. Hunt previously held the position of Senior Director-Pharma Programs at Applied Biosystems, Inc. and President-Bioproduction at Life Technologies Corp. Tony J. Hunt received an undergraduate degree and a graduate degree from National University of Ireland and an MBA from Questrom School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REPLIGEN CORPORATION
0.33% | 2024-03-17 | 183,249 ( 0.33% ) | 34 M $ | 2024-03-30 |
908 DEVICES INC.
0.03% | 2024-03-03 | 8,886 ( 0.03% ) | 67 089 $ | 2024-03-30 |
Tony Hunt active positions
| Companies | Position | Start |
|---|---|---|
| REPLIGEN CORPORATION | Chief Executive Officer | 2015-05-20 |
| 908 DEVICES INC. | Director/Board Member | 2022-03-01 |
Former positions of Tony Hunt
| Companies | Position | End |
|---|---|---|
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | 2013-12-31 |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Corporate Officer/Principal | 2007-12-31 |
Training of Tony Hunt
| National University of Ireland | Graduate Degree |
| Questrom School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| 908 DEVICES INC. | Health Technology |
| Private companies | 2 |
|---|---|
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |
- Stock Market
- Insiders
- Tony Hunt
